Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Abstract 5325: Inhibition of CD4+CD25+ regulatory T cell suppression to anti-tumor responses by OK-432 (lyophilized Streptococcus pyogenes)

Michiko Hirayama, Hiroyoshi Nishikawa, Yasuhiro Nagata, Takemasa Tsuji, Sahoko Hori, Masatoshi Aoki, Shugo Ueda, Hideaki Tahara, Shinichi Kageyama, Lloyd J. Old, Hiroshi Shiku, Sacha Gnjatic

Cancer Res (2010) 70 (8_Supplement): 5325.

https://doi.org/10.1158/1538-7445.AM10-5325

Published: 15 April 2010

View article titled, Abstract 5325: Inhibition of CD4+CD25+ regulatory T cell suppression to anti-tumor responses by OK-432 (lyophilized Streptococcus pyogenes)

Journal Articles

Abstract 2936: In situ antitumor immunotherapy with pharmacological blockade of MFG-E8 and chemotherapy against solid and hematological tumors

Masahisa Jinushi, Hideaki Tahara, Shigeo Koyasu, Glenn Dranoff

Cancer Res (2010) 70 (8_Supplement): 2936.

https://doi.org/10.1158/1538-7445.AM10-2936

Published: 15 April 2010

View article titled, Abstract 2936: <em>In situ</em> antitumor immunotherapy with pharmacological blockade of MFG-E8 and chemotherapy against solid and hematological tumors

Journal Articles

Abstract #2865: The role of tumor-derived MFG-E8 in triggering chemoresistance and immune suppression in patients with various solid tumors

Masahisa Jinushi, Marimo Sato, Akira Kanamoto, Akihiko Itoh, Martin Mihm, Glenn Dranoff, Hideaki Tahara

Cancer Res (2009) 69 (9_Supplement): 2865.

Published: 01 May 2009

View article titled, Abstract #2865: The role of tumor-derived MFG-E8 in triggering chemoresistance and immune suppression in patients with various solid tumors

Journal Articles

MFG-E8 derived from tumor-infiltrating myeloid cells plays a critical role in promoting tumor growth and metastasis

Masahisa Jinushi, Dobrin Draganov, Daniel Carrascco, Martin Mihm, Hideaki Tahara, Glenn Dranoff

Cancer Res (2008) 68 (9_Supplement): 4198.

Published: 01 May 2008

View article titled, MFG-E8 derived from tumor-infiltrating myeloid cells plays a critical role in promoting tumor growth and metastasis

Journal Articles

Systemic administration of IL-23 induces potent anti-tumor immunity primarily mediated through Th1-type response in association with the endogenously expressed IL-12

Marimo Sato, Hide Kaneda, Teruo Kaiga, Hideaki Tahara

Cancer Res (2008) 68 (9_Supplement): LB-133.

Published: 01 May 2008

View article titled, Systemic administration of IL-23 induces potent anti-tumor immunity primarily mediated through Th1-type response in association with the endogenously expressed IL-12

Journal Articles

Potent anti-tumor effects of combination therapy using Interleukin-23 and alpha-galactosylceramide

Hide Kaneda, Marimo Sato, Hideaki Tahara

Cancer Res (2007) 67 (9_Supplement): 969.

Published: 01 May 2007

View article titled, Potent anti-tumor effects of combination therapy using Interleukin-23 and alpha-galactosylceramide

Journal Articles

Development of anti-angiogenic cancer vaccine using epitope peptides derived from vascular endothelial growth factor receptor 1 (VEGFR1)

Hidenobu Ishizaki, Takuya Tsunoda, Satoshi Wada, Masabumi Shibuya, Hideaki Tahara

Cancer Res (2006) 66 (8_Supplement): 331.

Published: 15 April 2006

View article titled, Development of anti-angiogenic cancer vaccine using epitope peptides derived from vascular endothelial growth factor receptor 1 (VEGFR1)

Journal Articles

The role of endogenous interleukin-12 responses in antitumor effects of IL-23

Hide Kaneda, Marimo Sato, Hideaki Tahara

Cancer Res (2006) 66 (8_Supplement): 908.

Published: 15 April 2006

View article titled, The role of endogenous interleukin-12 responses in antitumor effects of IL-23

Journal Articles

Rationale for Antiangiogenic Cancer Therapy with Vaccination Using Epitope Peptides Derived from Human Vascular Endothelial Growth Factor Receptor 2

Satoshi Wada, Takuya Tsunoda, Toshiyuki Baba, F. James Primus, Hiroyuki Kuwano, Masabumi Shibuya, Hideaki Tahara

Cancer Res (2005) 65 (11): 4939–4946.

https://doi.org/10.1158/0008-5472.CAN-04-3759

Published: 01 June 2005

View article titled, Rationale for Antiangiogenic Cancer Therapy with Vaccination Using Epitope Peptides Derived from Human Vascular Endothelial Growth Factor Receptor 2

Journal Articles

Critical role of IFN-γ in the development of IL-23 anti-tumor activities

Teruo Kaiga, Marimo Sato, Tadatoshi Takayama, Hideaki Tahara

Cancer Res (2005) 65 (9_Supplement): 1414.

Published: 01 May 2005

View article titled, Critical role of IFN-γ in the development of IL-23 anti-tumor activities

Journal Articles

Vascular endothelial growth factor receptor2 as a promising target of cellular immunity in humans.

Satoshi Wada, Hidenobu Ishizaki, Hideaki Tahara, Takuya Tsunoda

Cancer Res (2004) 64 (7_Supplement): 496.

Published: 01 April 2004

View article titled, Vascular endothelial growth factor receptor2 as a promising target of cellular immunity in humans.

Journal Articles

Immunological monitoring of stage IV melanoma patients treated with vaccination using HLA-A*2402-restricted gp100 peptide

Toshiyuki Baba, Takuya Tsunoda, Hideaki Tahara

Cancer Res (2004) 64 (7_Supplement): 324.

Published: 01 April 2004

View article titled, Immunological monitoring of stage IV melanoma patients treated with vaccination using HLA-A*2402-restricted gp100 peptide

Journal Articles

Facilitation of dendritic cell differentiation using RNAi system to down-regulate VEGF secretion of tumor cells

Toshihiro Suzuki, Makoto Miyagishi, Marimo Sato, Hideaki Tahara, Kazunari Tahira

Cancer Res (2004) 64 (7_Supplement): 161.

Published: 01 April 2004

View article titled, Facilitation of dendritic cell differentiation using RNAi system to down-regulate VEGF secretion of tumor cells

Journal Articles

Successful induction of cytotoxic T-cells in colon cancer patients specific to RNF43 identified using genome-wide exploration of tumor-associated antigens using cDNA microarray profiling (GET-MAP)

Naotaka Uchida, Yoichi Furukawa, Yusuke Nakamura, Takako Suda, Hideaki Tahara, Hiroaki Tanaka, Takuya Tsunoda

Cancer Res (2004) 64 (7_Supplement): 1265.

Published: 01 April 2004

View article titled, Successful induction of cytotoxic T-cells in colon cancer patients specific to RNF43 identified using genome-wide exploration of tumor-associated antigens using cDNA microarray profiling (GET-MAP)

Journal Articles

Genome-wide exploration of tumor-associated antigens in gastro-intestinal cancer using cDNA microarray profiling

Takako Suda, Yoichi Furukawa, Yusuke Nakamura, Hideaki Tahara, Tsunoda Takuya, Hiroaki Tanaka, Naotaka Uchida

Cancer Res (2004) 64 (7_Supplement): 1261–1262.

Published: 01 April 2004

View article titled, Genome-wide exploration of tumor-associated antigens in gastro-intestinal cancer using cDNA microarray profiling

Journal Articles

Essential roles of type-1 helper T-cells in anti-tumor effects of IL-23

Teruo Kaiga, Marimo Sato, Hideaki Tahara, Tadatoshi Takayama

Cancer Res (2004) 64 (7_Supplement): 1082–1083.

Published: 01 April 2004

View article titled, Essential roles of type-1 helper T-cells in anti-tumor effects of IL-23

Journal Articles

Dendritic Cells Stimulated with a Bacterial Product, OK-432, Efficiently Induce Cytotoxic T Lymphocytes Specific to Tumor Rejection Peptide

Saori Nakahara, Takuya Tsunoda, Toshiyuki Baba, Shinichi Asabe, Hideaki Tahara

Cancer Res (2003) 63 (14): 4112–4118.

Published: 21 July 2003

View article titled, Dendritic Cells Stimulated with a Bacterial Product, OK-432, Efficiently Induce Cytotoxic T Lymphocytes Specific to Tumor Rejection Peptide

Journal Articles

Rapid Generation of Potent and Tumor-specific Cytotoxic T Lymphocytes by Interleukin 18 Using Dendritic Cells and Natural Killer Cells

Fumiaki Tanaka, Wataru Hashimoto, Haruki Okamura, Paul D. Robbins, Michael T. Lotze, Hideaki Tahara

Cancer Res (2000) 60 (17): 4838–4844.

Published: 01 September 2000

View article titled, Rapid Generation of Potent and Tumor-specific Cytotoxic T Lymphocytes by Interleukin 18 Using Dendritic Cells and Natural Killer Cells

Journal Articles

CC Chemokine Receptor-7 on Dendritic Cells Is Induced after Interaction with Apoptotic Tumor Cells: Critical Role in Migration from the Tumor Site to Draining Lymph Nodes

Motohiro Hirao, Nobuyuki Onai, Kazumasa Hiroishi, Simon C. Watkins, Kouji Matsushima, Paul D. Robbins, Michael T. Lotze, Hideaki Tahara

Cancer Res (2000) 60 (8): 2209–2217.

Published: 01 April 2000

View article titled, CC Chemokine Receptor-7 on Dendritic Cells Is Induced after Interaction with Apoptotic Tumor Cells: Critical Role in Migration from the Tumor Site to Draining Lymph Nodes

Journal Articles

Induction of Systemic and Therapeutic Antitumor Immunity Using Intratumoral Injection of Dendritic Cells Genetically Modified to Express Interleukin 12

Yasuhiko Nishioka, Motohiro Hirao, Paul D. Robbins, Michael T. Lotze, Hideaki Tahara

Cancer Res (1999) 59 (16): 4035–4041.

Published: 15 August 1999

View article titled, Induction of Systemic and Therapeutic Antitumor Immunity Using Intratumoral Injection of Dendritic Cells Genetically Modified to Express Interleukin 12

NARROW

Abstract 5325: Inhibition of CD4+CD25+ regulatory T cell suppression to anti-tumor responses by OK-432 (lyophilized Streptococcus pyogenes)

Abstract 2936: In situ antitumor immunotherapy with pharmacological blockade of MFG-E8 and chemotherapy against solid and hematological tumors

Abstract #2865: The role of tumor-derived MFG-E8 in triggering chemoresistance and immune suppression in patients with various solid tumors

MFG-E8 derived from tumor-infiltrating myeloid cells plays a critical role in promoting tumor growth and metastasis

Systemic administration of IL-23 induces potent anti-tumor immunity primarily mediated through Th1-type response in association with the endogenously expressed IL-12

Potent anti-tumor effects of combination therapy using Interleukin-23 and alpha-galactosylceramide

Development of anti-angiogenic cancer vaccine using epitope peptides derived from vascular endothelial growth factor receptor 1 (VEGFR1)

The role of endogenous interleukin-12 responses in antitumor effects of IL-23

Rationale for Antiangiogenic Cancer Therapy with Vaccination Using Epitope Peptides Derived from Human Vascular Endothelial Growth Factor Receptor 2

Critical role of IFN-γ in the development of IL-23 anti-tumor activities

Vascular endothelial growth factor receptor2 as a promising target of cellular immunity in humans.

Immunological monitoring of stage IV melanoma patients treated with vaccination using HLA-A*2402-restricted gp100 peptide

Facilitation of dendritic cell differentiation using RNAi system to down-regulate VEGF secretion of tumor cells

Successful induction of cytotoxic T-cells in colon cancer patients specific to RNF43 identified using genome-wide exploration of tumor-associated antigens using cDNA microarray profiling (GET-MAP)

Genome-wide exploration of tumor-associated antigens in gastro-intestinal cancer using cDNA microarray profiling

Essential roles of type-1 helper T-cells in anti-tumor effects of IL-23

Dendritic Cells Stimulated with a Bacterial Product, OK-432, Efficiently Induce Cytotoxic T Lymphocytes Specific to Tumor Rejection Peptide

Rapid Generation of Potent and Tumor-specific Cytotoxic T Lymphocytes by Interleukin 18 Using Dendritic Cells and Natural Killer Cells

CC Chemokine Receptor-7 on Dendritic Cells Is Induced after Interaction with Apoptotic Tumor Cells: Critical Role in Migration from the Tumor Site to Draining Lymph Nodes

Induction of Systemic and Therapeutic Antitumor Immunity Using Intratumoral Injection of Dendritic Cells Genetically Modified to Express Interleukin 12

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only